Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Pharmacokinetic, Safety, Tolerability, Immunogenicity, and Pharmacodynamic Study of SB12 in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03722329
Recruitment Status : Completed
First Posted : October 26, 2018
Last Update Posted : January 9, 2020
Information provided by (Responsible Party):
Samsung Bioepis Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 29, 2019
Actual Study Completion Date : April 8, 2019